Table 3 Measurable outcomes for the lung scoring systems for the evaluation of cranioventral pulmonary consolidation (CVPC) using the scoring method developed by Madec and Derrien ([20]; gold standard) and the four simplified scenarios
Scenario ID | Measurable outcome | |||||
|---|---|---|---|---|---|---|
Prevalence (%) | % of affected lung surface | N lobes affected | ||||
Mean (± SD) | Median (min.–max.) | Mean (± SD) | Median (min.–max.) | Mean (± SD) | Median (min.–max.) | |
Gold standard | 17 (± 1.5) | 13 (0–65) | 6.6 (± 2.75) | 6.2 (1.25–17.30) | 1.7 (± 0.48) | 1.6 (1.00–3.2) |
Scenario 1 Presence or absence of CVPC | 17 (± 1.5) | 13 (0–65) | Naa | Na | Na | Na |
Scenario 2 German scoring system | 17 (± 1.5) | 13 (0–65) | 8.5 (± 3.23) | 8.0 (5.00–23.00) | Na | Na |
Scenario 3 Number of lung lobes affected | 17 (± 1.5) | 13 (0–65) | 24.0b (± 6.80) | 23.5 (14.29–45.71) | 1.7 (± 0.48) | 1.6 (1.00–3.20) |
Scenario 4 Number of lung lobes affected excluding the intermediate lobe | 17 (± 1.5) | 12 (0–65) | 28.0c (± 7.83) | 27.4 (16.67–53.33) | 1.7 (± 0.47) | 1.7 (1.00–3.20) |